The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Damour Kevin since 2022.
This trader's CIK number is 1870486.
At the time of last reporting, Damour Kevin was the Chief Scientific Officer of Brooklyn Immunotherapeutics, Inc.. (stock ticker symbol BTX).
Also see all insider trading activities at Brooklyn Immunotherapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | BTX | 0 | $0 | 0 | $0 | 17,573 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-06-28 | BTX | Option Ex | 17,573 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Damour Kevin (Chief Scientific Officer of Brooklyn Immunotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.